Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs

Li, Genxia; Zhao, Shujun; Cui, Shihong; Li, Lei; Xu, Yajuan; Li, Yuanyuan
July 2015
Archives of Gynecology & Obstetrics;Jul2015, Vol. 292 Issue 1, p111
Academic Journal
Purpose: To compare the effects of metformin with insulin on maternal and neonatal outcomes in gestational diabetes mellitus (GDM). Methods: A literature search in PUBMED, EMBASE, Science Direct, Springer link, and Cochrane library was conducted using the following search terms: 'Gestational Diabetes' or 'GDM', and 'insulin' and 'metformin'. Quality assessment of included studies was determined with Quality Assessment of Diagnostic Accuracy Studies. Review Manger 5.2 was used to analyze mean difference (MD)/risk ratio (RR) and 95 % confidence interval (CI) in random-effects model or fixed-effects model depending on the level of heterogeneity. Results: A total of 11 studies were identified. There was no significant difference of the effect on maternal outcomes between the two treatments in glycohemoglobin A1c levels ( P = 0.37), fasting blood glucose ( P = 0.66), and the incidence of preeclampsia ( P = 0.26); whereas, significantly reduced results were found in the metformin group in pregnancy-induced hypertension (PIH) rate (RR = 0.53, 95 % CI 0.31-0.90, P = 0.02), average weight gains after enrollment (MD = −1.28, 95 % CI −1.54 to −1.01, P < 0.0001), and average gestational ages at delivery (MD = 0.94, 95 % CI −0.21 to −0.01, P = 0.03). Regarding neonatal outcomes, when compared with insulin group, metformin presented significantly lower average birth weights (MD = −44.35, 95 % CI −85.79 to −2.90, P = 0.04), incidence of hypoglycemia (RR = 0.69, 95 % CI 0.55-0.87, P = 0.001) and neonatal intensive care unit (NICU) (RR = 0.82, 95 % CI 0.67-0.99, P = 0.04). Conclusion: Metformin can significantly reduce several adverse maternal and neonatal outcomes including PIH rate, incidence of hypoglycemia and NICU, thus it may be an effective and safe alternative or additional treatment to insulin for GDM women.


Related Articles

  • COMPARISON BETWEEN METFORMIN AND INSULIN IN TREATMENT OF GESTATIONAL DIABETES MELLITUS AND EFFECT ON NEONATAL HYPOGLYCAEMIA. Ayub, Samra; Jaffar, Syed Raza; Basharat, Ayesha; Ayub, Waqas; Khan, Naseer Ahmed // Pakistan Armed Forces Medical Journal;10/31/2015, Vol. 65 Issue 5, p620 

    Objective: To compare the efficacy of metformin in the treatment of gestational diabetes mellitus (GDM) with insulin and to compare the frequency of hypoglycaemia in neonates of the mothers treated with metformin and insulin. Study Design: Randomized control trial to compare the efficacy of...

  • Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus and Associated Perinatal Outcome: a Randomized Clinical Trial. Mirzamoradi, Masoomeh; Heidar, Zahra; Faalpoor, Ziba; Naeiji, Zahra; Jamali, Razyeh // Acta Medica Iranica;2015, Vol. 53 Issue 2, p97 

    Insulin is currently the drug of choice in treating patients with gestational diabetes mellitus but insulin is expensive, inconvenient to store and use and probably associated with more risks of asymptomatic hypoglycemia in comparison with some oral agents. This randomized clinical trial was...

  • Entitymetrics: Measuring the Impact of Entities. Ding, Ying; Song, Min; Han, Jia; Yu, Qi; Yan, Erjia; Lin, Lili; Chambers, Tamy // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    This paper proposes entitymetrics to measure the impact of knowledge units. Entitymetrics highlight the importance of entities embedded in scientific literature for further knowledge discovery. In this paper, we use Metformin, a drug for diabetes, as an example to form an entity-entity citation...

  • Metformin in gestational diabetes: An emerging contender. Singh, Awadhesh Kumar; Singh, Ritu // Indian Journal of Endocrinology & Metabolism;Mar/Apr2015, Vol. 19 Issue 2, p236 

    Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance occurring first time during pregnancy. Its prevalence is simultaneously increasing with the global rise of diabesity. GDM commonly develops, when maternal glucose metabolism is unable to compensate for the...

  • Diabetic oncopathy - One more yet another deadly diabetic complication! Balasubramanyam, M. // Indian Journal of Medical Research;Jul2014, Vol. 140 Issue 1, p15 

    The article highlights the increasing number of diabetic oncopathy cases, which was first noticed by Maynard in 1910 after he observed that diabetes and cancer shares mostly similar features. Topics discussed include the role played by glucose metabolism abnormalities in the development of...

  • Role of Insulin Sensitizers in Raised Alanine Aminotransferase in Non-alcoholic Fatty Liver Disease in Glucose Intolerance Patients: A Short-Term Experience with Metformin Plus Pioglitazone Versus Metformin Alone. SULTANA, S. R.; AMIN, M. F.; RAHIM, M. A.; RAHMAN, M. M.; HOQUE, M. N.; BHUIAN, T. M.; DATTA, I. K.; RAHMAN, M. A. // Journal of Bangladesh College of Physicians & Surgeons;Oct2014, Vol. 32 Issue 4, p194 

    Objectives:To evaluate and compare the effectiveness of metformin plus pioglitazone versus metformin alone in treatment of raised alanine aminotransferase (ALT) in non- alcoholic fatty liver disease (NAFLD) in patients with newly detected diabetes mellitus (DM) and impaired glucose tolerance...

  • In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin. Carroll, Dana; Kelley, Kristi W. // Evidence Based Medicine;Aug2015, Vol. 20 Issue 4, p127 

    In this article, the authors comment on a study by M. Balsells related to the use of drugs like glibenclamide, metformin and insulin instead of the traditional insulin therapy to treat gestational diabetes mellitus (GDM) in women. It states that the study had several limitations such as maternal...

  • Dapagliflozin/metformin.  // Reactions Weekly;2/13/2016, Vol. 1588 Issue 1, p99 

    The article presents a case study of a 44-year-old man who has developed diabetic ketoacidosis & lactate acidosis during treatment with Dapagliflozin at dosage of 10mg once daily and Metformin at a dosage of 1000mg BID which was later increased to 3000mg. He developed high level of glucose in...

  • Secular Trends of Gestational Diabetes Mellitus and Changes in Its Risk Factors. Cho, Geum Joon; Kim, Log Young; Sung, Ye Na; Kim, Jee Ae; Hwang, Soon Young; Hong, Hye-Ri; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong // PLoS ONE;8/20/2015, Vol. 10 Issue 8, p1 

    Objective: The aim of this study was to evaluate the secular trends of incidence of gestational diabetes mellitus (GDM) and insulin treatment for GDM in a Korean population and to determine the factors that contribute to the trends in the incidence of GDM. Study Design: We used data collected...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics